Core Insights - Weisi Medical (688580) reported a closing price of 52.96 yuan as of August 29, 2025, down 3.22% from the previous week [1] - The company has a total market capitalization of 5.072 billion yuan, ranking 74th out of 126 in the medical device sector and 3279th out of 5152 in the A-share market [1] Shareholder Changes - As of June 30, 2025, the number of shareholders for Weisi Medical was 8095, an increase of 2162, or 36.44%, from March 31, 2025 [2][4] - The average number of shares held per shareholder decreased from 16,100 shares to 11,800 shares, with an average holding value of 550,000 yuan [2] Financial Performance - For the first half of 2025, Weisi Medical reported a main revenue of 210 million yuan, a year-on-year increase of 9.85% [3] - The net profit attributable to shareholders was 69.32 million yuan, up 39.71% year-on-year, while the net profit excluding non-recurring items was 63.57 million yuan, an increase of 46.3% [3][4] - In Q2 2025, the company achieved a single-quarter main revenue of 115 million yuan, a 10.23% year-on-year increase, with a net profit of 36.10 million yuan, up 29.56% year-on-year [3] - The company's debt ratio stands at 8.95%, with investment income of 6.59 million yuan and financial expenses of -1.90 million yuan, while the gross profit margin is 66.09% [3]
每周股票复盘:伟思医疗(688580)股东户数增36.44%,中报净利升39.71%